Institute for Follicular Lymphoma Innovation

The Institute for Follicular Lymphoma Innovation (IFLI) is a global non-profit private foundation based in Diamond Bar, CA, dedicated to accelerating innovative treatment options for follicular lymphoma patients through grants, partnerships, and venture philanthropy. The foundation manages over $26 million in assets and has committed over $20 million in funding over five years, with annual giving reaching $12,009,375 in 2024. IFLI funds research into FL biology, novel therapeutics, and biomarkers, recently announcing a collaboration with Tempus AI for a real-world data study to advance precision medicine. Leadership includes President Andrew Peykoff II, Managing Director Dave McCullagh, and CTO & Co-Founder Shwetha Lakshmipathi, Ph.D. The organization also partners with entities such as the Leukemia & Lymphoma Society (LLS) and Follicular Lymphoma Foundation (FLF). The Institute was founded in February 2022, with Shwetha Lakshmipathi listed as a co-founder.